BIO KEY INTERNATIONAL INC 8-K

What Happened BIO-key International, Inc. (ticker: BKYI) filed a Form 8-K on July 7, 2026 to disclose a press release announcing the reinstatement of trading of its common stock on the Nasdaq Capital Market. The press release is attached to the 8-K as Exhibit 99.1 and is incorporated by reference.

Key Details

• Filing date: July 7, 2026 (Form 8-K, Item 7.01 – Regulation FD Disclosure).
• Subject: Reinstatement of trading of BIO-key’s common stock on the Nasdaq Capital Market.
• Exhibit: Press release dated July 7, 2026 included as Exhibit 99.1 to the 8-K.
• Ticker: BKYI (common stock).

Why It Matters Reinstatement of Nasdaq trading restores the company’s shares to a national exchange, which generally improves liquidity and market access for retail and institutional investors. Investors should review the attached press release for the effective date and any conditions or details about the reinstatement, and monitor Nasdaq communications and company updates for any further information.